Cytokinetics
South San Francisco, CA
Cytokinetics, Incorporated operates as a clinical-stage biopharmaceutical company. The Company develops treatments for amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. Cytokinetics serves customers in the States of California and Pennsylvania.
cytokinetics.comCompany Details
Founded
- 1997
Employees
- 673 employees
Raised
- $3,215,449,856
Headquarters Location
- South San Francisco, CA
Public
- Yes
Acquired
- No
CEO
Robert Blum
Founders
- Lawrence GoldsteinRonald ValeJames SabryJames Spudich
Company Collections
These are collections Cytokinetics is a part of. Click on the collection name to view similar companies.
Current Job Listings
Cytokinetics Headquarters Location
Total Amount Raised: $3,215,449,856
Cytokinetics Funding Rounds
Post Ipo Equity
$805,000,000
Post Ipo Debt
$650,000,000
Post Ipo Equity
$550,000,000
Post Ipo Debt
$50,000,000
Post Ipo Debt
$450,000,000
Post Ipo Equity
$316,250,000
Post Ipo Equity
$201,300,000
Post Ipo Equity
$37,400,000
Post Ipo Equity
$42,500,000
Post Ipo Equity
$20,000,000
Post Ipo Equity
$33,000,000
IPO
Unknown
Series E
$40,000,000
Series B
$20,000,000
Cytokinetics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Cytokinetics.